<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>17</o:Revision>
  <o:TotalTime>469</o:TotalTime>
  <o:Created>2004-09-28T11:10:00Z</o:Created>
  <o:LastSaved>2004-10-05T13:12:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>834</o:Words>
  <o:Characters>4757</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>39</o:Lines>
  <o:Paragraphs>9</o:Paragraphs>
  <o:CharactersWithSpaces>5841</o:CharactersWithSpaces>
  <o:Version>9.4402</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
  <w:DrawingGridHorizontalSpacing>6 pt</w:DrawingGridHorizontalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>2</w:DisplayHorizontalDrawingGridEvery>
  <w:DisplayVerticalDrawingGridEvery>2</w:DisplayVerticalDrawingGridEvery>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-font-kerning:16.0pt;
	font-weight:bold;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
p
	{margin-right:0cm;
	mso-margin-top-alt:auto;
	mso-margin-bottom-alt:auto;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial Unicode MS";}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 89.85pt 72.0pt 89.85pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1029"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='text-decoration:none;text-underline:
none'><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:113.25pt;
 height:36.75pt'>
 <v:imagedata src="./Page2_files/image001.jpg" o:title="InterPro_logo"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=151 height=49
src="./Page2_files/image001.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>G Proteins<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>How G Proteins Work<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>The
first step in this complex signalling system involves the binding of specific
ligands (hormones, neurotransmitters, growth factors, glycoproteins, cytokines,
odorants and photons) at the cell surface to a GPCR, thereby activating the
receptor.<span style="mso-spacerun: yes">  </span>The signal is transmitted
into the cell via a conformational change in the receptor, which results in the
activation of the bound G protein.<span style="mso-spacerun: yes"> 
</span>GPCRs act as guanine nucleotide exchange factors for the <span
style='font-family:Symbol'>a</span> subunit of the G protein, whereby activated
receptor promotes the exchange of bound GDP (guanine diphosphate) for GTP on
the <span style='font-family:Symbol'>a</span> subunit, which is the
rate-limiting step in G protein activation.<span style="mso-spacerun: yes"> 
</span>The binding of GTP changes the conformation of ‘switch’ regions within
the <span style='font-family:Symbol'>a</span> subunit, which allows the bound
trimeric G protein (inactive) to be released from the receptor, and to
dissociate into active <span style='font-family:Symbol'>a</span> subunit
(GTP-bound) and <span style='font-family:Symbol'>bg</span> dimer.<span
style="mso-spacerun: yes">  </span>The <span style='font-family:Symbol'>a</span>
subunit and the <span style='font-family:Symbol'>bg</span> dimer go on to
activate distinct downstream effectors, such as <span style='mso-bidi-font-size:
10.0pt'>adenylyl cyclase, phosphodiesterases, phospholipase C, <a
href="http://www.ebi.ac.uk/interpro/potm/2003_2/Page_1.htm"
title="'Src' Protein of the Month">Src</a>, and ion channels.<span
style="mso-spacerun: yes">  </span>These effectors in turn regulate </span>the
intracellular concentrations of secondary messengers, such as cAMP, cGMP,
diacylglycerol, IP3, DAG, arachidonic acid, sodium, potassium or calcium
cations, which ultimately lead to a physiological response, usually via the
downstream regulation of gene transcription.<span style="mso-spacerun: yes"> 
</span>The cycle is completed by the hydrolysis of <span style='font-family:
Symbol'>a</span> subunit-bound GTP to GDP, resulting in the re-association of
the <span style='font-family:Symbol'>a</span> and <span style='font-family:
Symbol'>bg</span> subunits and their binding to the receptor, which terminates
the signal.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Regulation of G Proteins<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Heterotrimeric
G protein activity is regulated by the binding and hydrolysis of GTP by the <span
style='font-family:Symbol'>a</span> subunit.<span style="mso-spacerun: yes"> 
</span>Only the GTP-bound <span style='font-family:Symbol'>a</span> subunit is
active.<span style="mso-spacerun: yes">  </span>A GDP-bound <span
style='font-family:Symbol'>a</span> subunit is inactive, because the ‘switch’
regions in the <span style='font-family:Symbol'>a</span> subunit are free to
make contacts with the <span style='font-family:Symbol'>bg</span> dimer to form
a stable complex that does not readily allow GDP dissociation.<span
style="mso-spacerun: yes">  </span>The association of the subunits covers the
effector contact sites on both the <span style='font-family:Symbol'>a</span>
subunit and the <span style='font-family:Symbol'>bg</span> dimer, thereby
preventing all effector interactions and terminating the signal.<span
style="mso-spacerun: yes">  </span>Therefore, the length of the G protein
signal is controlled by the duration of GTP-bound <span style='font-family:
Symbol'>a</span> subunit.</p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>However,
by itself, the intrinsic level of GTP hydrolysis by the <span style='font-family:
Symbol'>a</span> subunit is too slow for the efficient cycling of G
proteins.<span style="mso-spacerun: yes">  </span>The lifespan of the GTP-bound
<span style='font-family:Symbol'>a</span> subunit can be markedly reduced by
RGS (regulator of G protein signalling) proteins (InterPro entry <a
href="http://www.ebi.ac.uk/interpro/DisplayIproEntry?ac=IPR000342"
title="InterPro entry for RGS proteins">I<span style='mso-bidi-font-size:9.0pt'>PR000342</span></a><span
style='mso-bidi-font-size:9.0pt;color:black'>)</span>.<span
style="mso-spacerun: yes">  </span>RGS proteins are multi-functional,
GTPase-accelerating proteins that promote <span style='font-family:Symbol'>a</span>
subunit GTP hydrolysis, thereby directly terminating <span style='font-family:
Symbol'>a</span> subunit signalling and indirectly terminating <span
style='font-family:Symbol'>bg</span> dimer signalling (through <span
style='font-family:Symbol'>a</span> subunit binding).<span style="mso-spacerun:
yes">  </span>RGS proteins promote GTP hydrolysis by stabilising the G protein
transition state, increasing the reaction rate by over two orders of
magnitude.<span style="mso-spacerun: yes">  </span>There are over thirty known
RGS proteins characterised in the human proteome alone.<span
style="mso-spacerun: yes">  </span>All RGS proteins contain an ‘RGS-box’
required for activity, while some also contain additional domains that confer
further functionality, such as coordinating cross-talk between heterotrimeric
and Ras-like G proteins.<span style="mso-spacerun: yes">  </span>In addition,
some C-family RGS proteins contain GGL (G protein <span style='font-family:
Symbol'>g</span>-like) domains that can interact with <span style='font-family:
Symbol'>b</span> subunits to form novel dimers that prevent <span
style='font-family:Symbol'>g</span> subunit binding.<span style="mso-spacerun:
yes">  </span>For example, in brain tissue <span style='font-family:Symbol'>b</span>5
subunit/RGS dimers have been detected, which may accelerate the deactivation of
GPCR signalling by enhancing GTP hydrolysis; they may also prevent heterotrimer
formation, as <span style='font-family:Symbol'>b </span>subunit/RGS dimers do
not appear to associate with <span style='font-family:Symbol'>a</span>
subunits.<span style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>The
covalent modification of G proteins is another way to regulate their
activity.<span style="mso-spacerun: yes">  </span>Heterotrimeric G proteins can
undergo a variety of covalent modifications, including lipid attachment and
phosphorylation.<span style="mso-spacerun: yes">  </span>Both the <span
style='font-family:Symbol'>a</span> subunit and <span style='font-family:Symbol'>bg</span>
dimer carry lipid modifications that target them to the membrane and affect
subunit interactions with each other and with other proteins.<span
style="mso-spacerun: yes">  </span>For example, some <span style='font-family:
Symbol'>a</span> subunits can contain covalently attached myristate or
palmitate moieties, which target the <span style='font-family:Symbol'>a</span>
subunit to the plasma membrane and contribute to the strength of interaction
with the <span style='font-family:Symbol'>bg</span> dimer, effectors and RGS
proteins.<span style="mso-spacerun: yes">  </span>Because the absence of lipid
modifications renders <span style='font-family:Symbol'>a</span> subunits
inactive, the regulation of reversible palmitoylation is a means of regulating <span
style='font-family:Symbol'>a</span> subunit activity.<span style="mso-spacerun:
yes">  </span>Protein modifications of the <span style='font-family:Symbol'>b</span>
and <span style='font-family:Symbol'>g</span> subunits are equally important,
with the isoprenylation of the <span style='font-family:Symbol'>g</span> subunit
with either farnesyl or geranylgeranyl groups being required for effector
regulation.</p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Phosphorylation
of G proteins appears to play a role in signal amplitude and duration.<span
style="mso-spacerun: yes">   </span>Some <span style='font-family:Symbol'>a</span>
subunits can be phosphorylated by protein kinase C or by p21-activated protein
kinase, which inhibits their interaction with either <span style='font-family:
Symbol'>bg</span> dimers or with RGS proteins, thereby prolonging the
signal.<span style="mso-spacerun: yes">  </span>Conversely, the phosphorylation
of a <span style='font-family:Symbol'>g</span> subunit by protein kinase C
increases the strength of its interaction with an <span style='font-family:
Symbol'>a</span> subunit and decreases its interaction with effectors, thereby
quenching a signal.<span style="mso-spacerun: yes">  </span>The phosphorylation
of <span style='font-family:Symbol'>bg</span> dimers may also act as an
activation step by providing receptor specificity.<span style="mso-spacerun:
yes">  </span>Receptor activation can change the pattern of G protein
modifications.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1 align=center style='text-align:center'>Next:<span style="mso-spacerun:
yes">  </span><a href="Page3.htm" title="To next page">When G Protein
Signalling is Disrupted</a></h1>

<h1 align=center style='text-align:center'>Previous:<span style="mso-spacerun:
yes">  </span><a href="Page1.htm" title="To previous page">G Proteins, Cell
Regulators</a></h1>

<p style='margin:0cm;margin-bottom:.0001pt'><span style='font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p style='margin:0cm;margin-bottom:.0001pt'><span style='font-family:"Times New Roman";
mso-fareast-font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
